Comparative Genomics Revealed Fluoroquinolone Resistance Determinants and OmpF Deletion in Carbapenem-Resistant Escherichia coli
- PMID: 35516434
- PMCID: PMC9062692
- DOI: 10.3389/fmicb.2022.886428
Comparative Genomics Revealed Fluoroquinolone Resistance Determinants and OmpF Deletion in Carbapenem-Resistant Escherichia coli
Erratum in
-
Corrigendum: Comparative genomics revealed fluoroquinolone resistance determinants and OmpF deletion in carbapenem-resistant Escherichia coli.Front Microbiol. 2022 Nov 24;13:1094324. doi: 10.3389/fmicb.2022.1094324. eCollection 2022. Front Microbiol. 2022. PMID: 36504834 Free PMC article.
Abstract
Escherichia coli (E. coli) is a major causative organism of complicated urinary tract infections, bloodstream infections, and pneumonia. With the widespread use of antimicrobial agents, the prevalence of carbapenem resistance in E. coli has been increasing with limited therapeutic options. Fluoroquinolone remains a choice in carbapenem-resistant E. coli (CREc) that were once susceptible to the drug. Despite robust studies on the fluoroquinolone-resistant mechanisms of E. coli, few studies focused specifically on the group of CREc. In this study, we used comparative genomics to identify the fluoroquinolone-resistant mechanisms of CREc and detected gyrA D87N mutation in all the fluoroquinolone-resistant and CREc. Moreover, to investigate the mechanism underlying non-carbapenemase-producing carbapenem-resistant E. coli, we targeted the complete genome sequences for in-depth analysis and found a deletion in OmpF (DEL264-269) that might contribute to carbapenem resistance, which has not been reported before. Further studies focusing on the impact of these mutations on the expression levels are warranted. We further investigate the MLST, serotype, fimH type, phylogroup, and clinical characteristics of the CREc. Combination analysis of clinical and genomic characteristics suggests the polyclonal and highly diverse nature of the CREc in Taiwan. This study provides an insight into the molecular epidemiology of CREc in Taiwan.
Keywords: Escherichia coli; carbapenem-resistant; carbapenemase; epidemiology; virulence; whole-genome sequencing.
Copyright © 2022 Yang, Chiu, Huang and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Epidemiology and Genetic Characteristics of Carbapenem-Resistant Escherichia coli in Chinese Intensive Care Unit Analyzed by Whole-Genome Sequencing: a Prospective Observational Study.Microbiol Spectr. 2023 Feb 21;11(2):e0401022. doi: 10.1128/spectrum.04010-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36802220 Free PMC article.
-
Corrigendum: Comparative genomics revealed fluoroquinolone resistance determinants and OmpF deletion in carbapenem-resistant Escherichia coli.Front Microbiol. 2022 Nov 24;13:1094324. doi: 10.3389/fmicb.2022.1094324. eCollection 2022. Front Microbiol. 2022. PMID: 36504834 Free PMC article.
-
In vitro Synergistic Activities of Fosfomycin in Combination with Other Antimicrobial Agents Against Carbapenem-Resistant Escherichia coli Harboring bla NDM-1 on the IncN2 Plasmid and a Study of the Genomic Characteristics of These Pathogens.Infect Drug Resist. 2022 Apr 12;15:1777-1791. doi: 10.2147/IDR.S357965. eCollection 2022. Infect Drug Resist. 2022. PMID: 35437346 Free PMC article.
-
Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.Antimicrob Agents Chemother. 2020 Apr 21;64(5):e02408-19. doi: 10.1128/AAC.02408-19. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32152073 Free PMC article.
-
Carbapenem-resistant Enterobacter cloacae complex in a tertiary Hospital in Northeast China, 2010-2019.BMC Infect Dis. 2021 Jun 26;21(1):611. doi: 10.1186/s12879-021-06250-0. BMC Infect Dis. 2021. PMID: 34174823 Free PMC article.
Cited by
-
The Antimicrobial Resistance (AMR) Rates of Enterobacterales in a Rural Hospital from the Eastern Region, Ghana: A Retrospective Study, 2022.Antibiotics (Basel). 2023 Aug 16;12(8):1321. doi: 10.3390/antibiotics12081321. Antibiotics (Basel). 2023. PMID: 37627741 Free PMC article.
References
-
- Abd El Ghany M., Sharaf H., Al-Agamy M. H., Shibl A., Hill-Cawthorne G. A., Hong P. Y. (2018). Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia. PLoS ONE. 13, e0201613. 10.1371/journal.pone.0201613 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources